StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
DelistingApr 17, 2026, 04:16 PM

Avalon GloboCare Notifies of Nasdaq Minimum Bid Price Non-Compliance

AI Summary

Avalon GloboCare Corp. (ALBT) received a notice from Nasdaq on April 15, 2026, indicating non-compliance with the minimum bid price requirement of $1.00 per share. The company's common stock traded below this threshold for 30 consecutive business days from March 1 to April 14, 2026. ALBT has 180 calendar days, until October 12, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. The notice does not immediately affect the trading of its common stock on The Nasdaq Capital Market.

Key Highlights

  • Received Nasdaq notice on April 15, 2026, for minimum bid price non-compliance.
  • Failed to maintain $1.00 bid price for 30 consecutive business days.
  • Has 180 calendar days, until October 12, 2026, to regain compliance.
  • Must achieve $1.00 closing bid for 10 consecutive business days.